Redhill Biopharma
RDHL
$0.47
Share price
-1.72%
Change (1 day)
-78.76%
Change (1 year)
Categories
Market capitalization of Redhill Biopharma (RDHL)
Market cap: $15.09 Million
As of May 2024 Redhill Biopharma has a market cap of $15.09 Million. This makes Redhill Biopharma the world's 8068th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Redhill Biopharma from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $15.09 M | -47.46% |
| 2023 | $28.72 M | 124.48% |
| 2022 | $12.79 M | -90.54% |
| 2021 | $0.13 B | -55.61% |
| 2020 | $0.30 B | 42.27% |
| 2019 | $0.21 B | 35.97% |
| 2018 | $0.15 B | 43.99% |
| 2017 | $0.10 B | -38.72% |
| 2016 | $0.17 B | 8.98% |
| 2015 | $0.16 B | 39.76% |
| 2014 | $0.11 B | 54.16% |
| 2013 | $75.99 M |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Redhill Biopharma was reported to be:
$15.09 Million
$15.09 Million
$15.09 Million
$0.42 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $122.00 B | 808,329.23% | 🇫🇷 France |
 Merck MRK | $332.27 B | 2,201,561.17% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $94.75 B | 627,733.55% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $18.89 B | 125,070.70% | 🇮🇱 Israel |
 Taro Pharmaceutical TARO | $1.58 B | 10,434.10% | 🇮🇱 Israel |